VLMS Partnership Brevitas recently launched the ValGenesis product suite in partnership with ValGenesis, Inc., signaling a strong capability in enterprise validation lifecycle management. This creates a clear cross-sell path to life sciences clients needing end-to-end validation, CSV, and data integrity services aligned with VLMS deployments. Opportunities include bundled validation consulting, IQ/OQ/PQ execution, CSV documentation, and change management support during VLMS implementation, targeting mid-market pharma, biotech, and medical device companies in the US and Canada.

Quality and Compliance Brevitas focuses on CQV, CSV, data integrity, quality, regulatory affairs, and training, positioning them to help life sciences organizations meet stringent compliance and validation requirements. Use this to propose end-to-end readiness assessments, remediation programs, and ongoing training to sustain compliant operations. Target manufacturers and labs needing ISO 13485 aligned processes, software validation, and robust data governance.

North America Growth With a Durham, NC base and a stated mission to be a leading partner for life science companies, Brevitas is well positioned to scale across the US and Canada. The ValGenesis collaboration supports scalable deployments across regional clients, CROs, CMOs, and healthcare product companies seeking faster time-to-market and regulatory readiness.

Tech Enabled Delivery The technology stack includes Google Cloud, SCADA, VMware and ISO 13485 expertise, indicating strong capabilities to deliver validated, cloud-enabled GMP and ISO-compliant projects. Leverage this to pitch cloud-based validation programs, data integrity initiatives, automated process improvements, and scalable validation documentation.

Growth Momentum With an established mid-market scale and a growing services portfolio, Brevitas demonstrates stability and momentum for multi-year engagements. This supports framing opportunities for long-term programs in program delivery, Lean Six Sigma process optimization, regulatory affairs outsourcing, and ongoing training across life sciences clients.